Who owns the ALLYX THERAPEUTICS trademark?

The ALLYX THERAPEUTICS trademark is owned by Allyx Therapeutics, Inc..

What class is the ALLYX THERAPEUTICS trademark registered in?

The ALLYX THERAPEUTICS trademark is registered in Class 042 (Scientific, technology & SaaS services).

What is the serial number for ALLYX THERAPEUTICS?

The USPTO serial number for ALLYX THERAPEUTICS is 97282640.

What is the registration number for ALLYX THERAPEUTICS?

ALLYX THERAPEUTICS is registered under USPTO registration number 7017044.

Sealvo

Home Search: ALLYX THERAPEUTICSALLYX THERAPEUTICS #97282640

Back

Updated Oct 26, 2026·34 searches this week

View on USPTO TSDR Find similar marks

ALL

USPTO Trademark Record

REGISTERED

ALLYX THERAPEUTICS

SN 97282640·Reg 7017044·Filed Feb 24, 2022

Owner Allyx Therapeutics, Inc.

Scientific and technological services and research and design relating thereto; industrial analysis, industrial research and industrial design services; quality control and authentication services; design and development of computer hardware and software.

ALLYX THERAPEUTICS (Serial No. 97282640), Registration No. 7017044, is a registered US trademark filed on Feb 24, 2022 by Allyx Therapeutics, Inc.. This trademark covers Class 042 (Scientific, technology & SaaS services).

early section 8: April 04, 2029

Mark Intelligence

ALLYX THERAPEUTICS (Reg. #7017044) is a registered US trademark that has been protecting its owner, Allyx Therapeutics, Inc., since 2022. The mark covers Class 042 (Scientific, technology & SaaS services). Goods and services include Scientific and technological services and research and design relating thereto; industrial analysis, industrial research.... The mark faced 1 opposition proceeding during prosecution.

FILED

Feb 24, 2022

SERIAL

97282640

REG#

7017044

REGISTERED

Apr 04, 2023

Filing Information

StatusREGISTERED

Filing DateFeb 24, 2022

Serial Number97282640

Registration No.7017044

Registration DateApr 04, 2023

Status DateApr 04, 2023

Published for OppositionJan 17, 2023

Filing Basis & Declarations

Standard Characters ClaimedFiled as Use ApplicationUse Application Currently

Full Goods & Services

CLASSES

OFFICE

USPTO

COUNTRY

Class 042Scientific, technology & SaaS services

US codes: 100, 101

First use anywhere: Oct 23, 2018

First use in commerce: Oct 23, 2018

This description is as filed with the USPTO and defines the scope of trademark protection.

Run a conflict check

Search by serial number, mark name, or logo. See conflicting marks ranked by risk with clear explanations of what contributed.

Run conflict check

Status History

13 events

REGISTERED-PRINCIPAL REGISTER

Apr 04, 2023

REGISTERED-PRINCIPAL REGISTER

NOTICE OF REGISTRATION CONFIRMATION EMAILED

Apr 04, 2023

NOTICE OF REGISTRATION CONFIRMATION EMAILED

PUBLISHED FOR OPPOSITION

Jan 17, 2023

PUBLISHED FOR OPPOSITION

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Jan 17, 2023

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

Dec 28, 2022

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

EXAMINERS AMENDMENT -WRITTEN

Dec 14, 2022

EXAMINERS AMENDMENT -WRITTEN

EXAMINERS AMENDMENT E-MAILED

Dec 14, 2022

EXAMINERS AMENDMENT E-MAILED

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

Dec 14, 2022

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

EXAMINER'S AMENDMENT ENTERED

Dec 14, 2022

EXAMINER'S AMENDMENT ENTERED

APPROVED FOR PUB - PRINCIPAL REGISTER

Dec 14, 2022

APPROVED FOR PUB - PRINCIPAL REGISTER

ASSIGNED TO EXAMINER

Dec 08, 2022

ASSIGNED TO EXAMINER

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Mar 02, 2022

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

NEW APPLICATION ENTERED

Feb 28, 2022

NEW APPLICATION ENTERED

Other Marks by Allyx Therapeutics, Inc.

Additional USPTO filings from the same owner.

ALL

ALLYX THERAPEUTICS

99923698

Allyx Therapeutics, Inc.

PENDING

ALL

ALLYX THERAPEUTICS

97282621

Allyx Therapeutics, Inc.

ABANDONED

Other Marks in Class 042 — Scientific, technology & SaaS services

Recently filed and registered marks in the same international class.

VIM

VIMA THERAPEUTICS

98166904

Vima Therapeutics, Inc.

REGISTERED

SAP

SAPIENCE THERAPEUTICS

86872810

Sapience Therapeutics, Inc.

REGISTERED

KEE

KEENOVA THERAPEUTICS

79445783

Mallinckrodt Pharmaceuticals Ireland Limited

REGISTERED

DEL

DELPHIAN THERAPEUTICS

98830481

Schedule 1 Therapeutics, Inc.

REGISTERED

Other Marks by David Ewen

Additional USPTO filings handled by the same attorney of record.

CBC

CB COLDWELL BANKER

88752534

REGISTERED

CBC

CB COLDWELL BANKER

88752537

REGISTERED

COR

CORCORAN NEW DEVELOPMENT

88782564

REGISTERED

COR

CORCORAN NEW DEVELOPMENT

88782626

REGISTERED

ALLYX THERAPEUTICS

Run a conflict check

Other Marks by Allyx Therapeutics, Inc.

Other Marks in Class 042 — Scientific, technology & SaaS services

Other Marks by David Ewen

Get pre-filing clearance

Search 14M+ trademarks

Industries

USPTO Deadlines

Compare

Resources

Company